The government is under pressure to pay for another costly cancer 'wonder drug'. It's not the first time the media have weighed in on how the nation's pharmaceutical budget should be spent, egged on by vested interests.
Recent stories from Mediawatch
Get the RNZ app
for easy access to all your favourite programmes
